Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03668431
Title Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

colorectal cancer

Therapies

Dabrafenib + Spartalizumab + Trametinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST